Abstract
Background Human papillomavirus (HPV) positivity (+) has been used to identify oropharyngeal squamous carcinomas (SCCs) presenting as unknown primaries in the neck. p16 overexpression correlates with HPV+ in the oropharynx; however, the use of p16 alone as a surrogate marker of oropharyngeal HPV+ tumors has not been validated. Methods We immunohistochemically analyzed p16 expression in surgically resected aggressive cutaneous head and neck SCC primaries and their nodal metastases from 24 patients to determine the potential overlap of p16 expression outside of the oropharynx. Results Five of 24 primary tumors (20.8%) and 3 lymph node metastases (12.5%) in levels II, III, and V, and the periparotid region diffusely expressed p16. HPV (high-risk types by in situ hybridization) was negative. Conclusions p16 expression is relatively common in lymph node-positive cutaneous head and neck SCCs; thus, p16 expression as an independent biomarker and mechanism to determine the oropharyngeal source of an unknown primary is not advised.
Original language | English (US) |
---|---|
Pages (from-to) | 1527-1533 |
Number of pages | 7 |
Journal | Head and Neck |
Volume | 35 |
Issue number | 11 |
DOIs | |
State | Published - Nov 2013 |
Keywords
- cutaneous squamous carcinoma
- neck metastases
- p16
- unknown primary
ASJC Scopus subject areas
- Otorhinolaryngology
MD Anderson CCSG core facilities
- Clinical Trials Office